New York, Dec. 19, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Pigmented Villonodular Synovitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and ...

Please provide your email address to receive an email when new articles are posted on . Douglas W. Jackson, MD, asks 4 questions of Joshua S. Dines, MD, about the history of PVNS. While it is an ...

Please provide your email address to receive an email when new articles are posted on . A 60-year-old woman presented to us with newly diagnosed breast cancer. She had a screening mammogram that ...

Advanced phase I/II evaluation of tumor-targeted gene delivery: Intravenous retrovector encoding mutant anticyclin G1 as stand-alone therapy for chemotherapy-resistant bone and soft tissue sarcoma.

We report an unusual case of Langerhans cell granulomatosis (LCG) manifested as a villous synovial proliferation in a 38-year-old female jogger. One year after the onset of joint symptoms, she had a ...

A pilot study of PLX3397, a selective colony-stimulating factor 1 receptor (CSF1R) kinase inhibitor, in pigmented villonodular synovitis (PVNS). This is an ASCO Meeting Abstract from the 2014 ASCO ...

We herein describe three cases of pigmented villonodular synovitis with chondroid metaplasia. Two cases involved the temporomandibular joint, whereas the remaining one case occurred in the hip joint.

A 47-year-old white woman presents with right knee villonodular synovitis. Three years ago she underwent synovectomy. Two months ago she presented with right knee pain with impressive swelling. What ...

A previously well 30 year old man presented with a short history of intra-articular mechanical locking, swelling, and anteromedial joint line pain. There was localised tenderness, and McMurray’s test ...